European Commission logo
English English
CORDIS - EU research results
Content archived on 2024-06-18

Role of palladin for actin filament organization in podocytes foot processes

Final Activity Report Summary - PALLADIN (Role of palladin for actin filament organization in podocytes foot processes)

Podocytes are injured in many forms of human and experimental glomerular disease such as focal segmental glomelurosclerosis, diabetic nephropathy, and crescentic glomerulonephritis. The singularity of the actin cytoskeleton in podocytes and its critical role for podocyte function is well known. Indeed, podocytes express unique actin-associated proteins such as synaptopodin, mutation or absence of a-actinin-4 result in glomerulosclerosis, and several stimuli like polycations and mechanical stress are known to induce rapid and profound reorganization of the actin cytoskeleton in podocytes.

On the basis of earlier, preliminary results we have established in this project:
1) that palladin is expressed in podocytes in the kidney;
2) that palladin associates with various other actin-associated proteins in contractile actin bundles and focal adhesions in podocytes;
3) that palladin most likely acts as a dynamic scaffolding protein in actin structures of podocytes as opposed to a stable structural role;
4) that palladin is essential for the formation of dynamic actin structures in podocytes;
5) that palladin appears to play a role in kidney disease, since it is specifically downregulated in the glomeruli of patients with focal segmental glomerulosclerosis.

Further results obtained in this project suggest that palladin interacts with actin-associated proteins anchoring the podocyte slit diaphragm, and that palladin controls actin filament elongation and contractile force in podocytes via interaction with specific proteins.

The results of this project have important implications for our understanding of actin filament formation and force development in foot processes in podocytes. They may open new strategies to prevent or even to reverse the loss of podocyte foot processes in kidney disease.